In Brief
Lithia mineral water pegged as new drug; FDA warns Parrillo on unverified CofAs; Takeda markets Tylenol in Japan; CSPI sues J&J/McNeil over Splenda health claims; Harkin reports on pending health care cuts; more news In Brief.
Lithia mineral water pegged as new drug; FDA warns Parrillo on unverified CofAs; Takeda markets Tylenol in Japan; CSPI sues J&J/McNeil over Splenda health claims; Harkin reports on pending health care cuts; more news In Brief.